← back to search

Li Zhang

Nanjing University · US
🔎 Find collaborators in Pulmonary and Respiratory Medicine · Infectious Diseases →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pulmonary and Respiratory Medicine · Infectious Diseases
Research interest
Research interests include Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, and COVID-19 Clinical Research Studies.
h-index
33
citations
16,310
works
186
NIH funding
primary concept
Medicine
email

Recent publications

A retrospective cross-sectional study of association between triglyceride-glucose index and carotid atherosclerosis
Frontiers in Cardiovascular Medicine 2025cited by 4position: middledoi
1348 Final overall survival analysis of HARMONi-A study comparing ivonescimab plus chemotherapy to chemotherapy alone in patients with EGFR <sup>+</sup> NSCLC progressed on EGFR-TKI treatment
2025cited by 2position: firstdoi
Sacituzumab tirumotecan (sac-TMT) in combination with tagitanlimab (anti-PD-L1) in first-line (1L) advanced non-small-cell lung cancer (NSCLC): Non-squamous cohort from the phase II OptiTROP-Lung01 study.
Journal of Clinical Oncology 2025cited by 2position: lastdoi
Clinical features and outcomes of unresectable locally advanced lung adenocarcinoma with uncommon EGFR mutations: a retrospective multi-center Chinese study
Translational Lung Cancer Research 2025cited by 1position: middledoi
Efficacy, safety, and quality of life of dabrafenib plus trametinib treatment in Chinese patients with BRAFV600E mutation-positive metastatic non-small cell lung cancer
Translational Lung Cancer Research 2024cited by 5position: lastdoi
Electroacupuncture activates the peroxisome proliferators‐activated receptor pathway to improve the phenotype of cerebral palsy
CNS Neuroscience & Therapeutics 2024cited by 3position: middledoi
Associations between cardiometabolic disease severity, social determinants of health (SDoH), and poor COVID‐19 outcomes
Obesity 2022cited by 17position: middledoi
Real-world treatment patterns and clinical outcomes in EGFR-mutant locally advanced lung adenocarcinoma: A multi-center cohort study
Journal of the National Cancer Center 2022cited by 12position: middledoi
Comparison of Visual Neuroadaptations After Multifocal and Monofocal Intraocular Lens Implantation
Frontiers in Neuroscience 2021cited by 34position: firstdoi
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
JAMA Internal Medicine 2020cited by 8,731position: middledoi
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
Annals of Oncology 2020cited by 1,548position: firstdoi
Real-world treatment patterns and clinical outcomes in <i>EGFR</i>-mutant unresectable locally advanced NSCLC (LA-NSCLC): A retrospective multicenter study of 367 patients.
Journal of Clinical Oncology 2020cited by 4position: middledoi
Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With <i>EGFR</i>-Mutated, MET Factor–Dysregulated Non–Small-Cell Lung Cancer
Journal of Clinical Oncology 2018cited by 330position: middledoi
Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer
Lung Cancer 2018cited by 108position: middledoi
miR-608 and miR-4513 significantly contribute to the prognosis of lung adenocarcinoma treated with EGFR-TKIs
Laboratory Investigation 2018cited by 33position: middledoi
Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial
The Lancet Respiratory Medicine 2017cited by 185position: middledoi
AC0010, an Irreversible EGFR Inhibitor Selectively Targeting Mutated EGFR and Overcoming T790M-Induced Resistance in Animal Models and Lung Cancer Patients
Molecular Cancer Therapeutics 2016cited by 86position: lastdoi
Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy
Oncotarget 2015cited by 110position: middledoi
Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study
Japanese Journal of Clinical Oncology 2015cited by 8position: middledoi
EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey
Journal of Thoracic Oncology 2014cited by 186position: middledoi
Gefitinib Alone or with Concomitant Whole Brain Radiotherapy for Patients with Brain Metastasis from Non-small-cell Lung Cancer: A Retrospective Study
Asian Pacific Journal of Cancer Prevention 2012cited by 72position: middledoi

Grants

Collaborative Research: Ideas Lab: Breaking Low: DRIVE-SAFE: Remote and Cooperative Autonomous Driving in Dynamic Environments using 5G/NextG Technology
NSF2453815$2,544,6262025–2027PIRePORTER
Doctoral Dissertation Research: Digital Management of Eldercare and Aging
NSF2517798$31,1702025–2026PIRePORTER
Travel: Student Support for SDM 2025 (SIAM International Conference on Data Mining)
NSF2529965$25,0002025–2027PIRePORTER
Collaborative Research: CISE MSI: RDP: III: Towards Robust and Human-Aligned Deep Learning for Medical-Sensor Time Series
NSF2431514$260,0002024–2027PIRePORTER
Collaborative Research: CISE: Large: Integrated Networking, Edge System and AI Support for Resilient and Safety-Critical Tele-Operations of Autonomous Vehicles
NSF2321531$2,306,2502023–2027PIRePORTER
CNS Core:Medium: NFLambda -- A Granular, Scalable and Secure NFV Framework for High Performance Packet Processing at 100 Gbps and Beyond
NSF2106771$1,216,0002021–2026PIRePORTER
Collaborative Research:SWIFT: Exploiting Application Semantics in Intelligent Cross-Layer Design to Enhance End-to-End Spectrum Efficiency
NSF2128489$480,9952021–2025PIRePORTER
CNS Core: Medium: Collaborative: Exploring and Exploiting Learning for Efficient Network Control: Non-Stationarity, Inter-Dependence, and Domain-Knowledge
NSF1901103$331,3332019–2024PIRePORTER
SCC: Leveraging Autonomous Shared Vehicles for Greater Community Health, Equity, Livability, and Prosperity (HELP)
NSF1831140$1,750,8562018–2023PIRePORTER
ICE-T:RC: Accelerating NFV Service Function Chain Processing at Scale
NSF1836772$349,8902018–2023PIRePORTER
NeTS: Small: Collaborative Research: Lightweight Adaptive Algorithms for Network Optimization at Scale towards Emerging Services
NSF1814322$227,7452018–2023PIRePORTER
NeTS: Small: Exerting Logically Centralized Control over Legacy Switches via Incremental SDN Deployment
NSF1618339$350,0002016–2021PIRePORTER
NeTS: Small: Diverse and Resilient Beyond Paths
NSF1617729$299,9812016–2021PIRePORTER
NeTS: Large: Collaborative Research: Complex Interactions in the Content Distribution Ecosystem
NSF1411636$643,6562014–2019PIRePORTER
Doctoral Dissertation Research: Consumer Demand in Postsocialist China
NSF1155809$19,9752012–2014PIRePORTER
NeTS: Small: Understanding, Managing and Trouble-Shooting the Evolving Cellular Data Networks
NSF1117536$300,0002011–2016PIRePORTER
NeTSE: Small: Spatio-Temporal Network Traffic Dynamics and Interactions of Social-Technical Networks
NSF1017647$516,0002010–2015PIRePORTER
NeTS: Small: VIRO: Highly Scalable, Robust and Namespace Independent Routing for Future Networks
NSF1017092$436,0002010–2015PIRePORTER
Culturing Psychotherapy, Transforming Selfhood in Postsocialist China
NSF0959371$148,2302010–2013PIRePORTER
Modeling and Identification of multi-joint arm dynamics post stroke
NSF0854498$290,8182009–2014PIRePORTER
CAREER: Categorical Shape Reconstruction
NSF0845916$266,4062009–2015PIRePORTER
NeTS: Medium: Collaborative Research: Towards Versatile and Programmable Measurement Architecture for Future Networks
NSF0905037$200,0002009–2012PIRePORTER
Collaborative Research: FIND - On the Economic Viability of Network Architectures
NSF0721510$550,0002007–2011PIRePORTER
CRI: IAD Research Infrastructure for Emerging Networked Systems and Applications
NSF0709048$199,9992007–2009PIRePORTER

Frequent collaborators

Xu Zhang · Shanxi Medical University3 papers (2020–2025)Fei Xu · Nanchang University3 papers (2012–2025)Kunpeng Xu · Ministry of Education of the People's Republic of China3 papers (2020–2025)Chunxue Bai · Fudan University3 papers (2015–2020)Lühua Wang · Hubei University of Medicine3 papers (2020–2025)Chen Hu · Southeast University3 papers (2020–2025)Lujun Zhao · Guiyang Medical University3 papers (2020–2025)Nan Bi · Chinese Academy of Medical Sciences & Peking Union Medical College3 papers (2020–2025)Yong Song · Nanjing University of Chinese Medicine2 papers (2017–2018)Yi‐Long Wu · China Agricultural University2 papers (2017–2018)Jiancheng Li · Yangtze University2 papers (2020–2025) · 2 papers (2025–2025)Yi-Sheng Huang · Beibu Gulf University2 papers (2015–2017)Yin-duo Zeng · Sun Yat-sen University2 papers (2012–2015)Li-kun Chen · Hebei Agricultural University2 papers (2012–2015)Hong Ge · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2020–2025)Jianzhong Cao · Shanxi Medical University2 papers (2020–2025)E Mingyan · Harbin Medical University2 papers (2020–2025)Ying Cheng · Changzhi University2 papers (2017–2025)Hai Liao · Southwest Jiaotong University2 papers (2012–2015)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pulmonary and Respiratory Medicine · Infectious Diseases →